Phase I Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics of 3 Dosages of Estetrol, the Lowest Dose of 2 mg Estetrol Compared With 2 mg of E2, After Daily Oral Administration for 28 Days in Healthy Postmenopausal Women.
Phase of Trial: Phase I
Latest Information Update: 18 May 2012
At a glance
- Drugs Estetrol; Estradiol
- Indications Menopausal syndrome
- Focus Adverse reactions
- 23 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2011 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
- 28 Oct 2006 New trial record.